The protein capping and the drug release strategy were also studied for “transferrin-capped MSNs (DOX@MSNs-S-S-Tf), which showed cancer-targeting effects and released DOX through uncapping transferrin because of disulfide link destabilization. Here, TF is linked to cancer.